53.36
price down icon3.05%   -1.68
after-market アフターアワーズ: 53.36
loading
前日終値:
$55.04
開ける:
$54.1
24時間の取引高:
451.35K
Relative Volume:
0.68
時価総額:
$1.58B
収益:
$232.39M
当期純損益:
$-26.79M
株価収益率:
-49.39
EPS:
-1.0804
ネットキャッシュフロー:
$4.41M
1週間 パフォーマンス:
-1.46%
1か月 パフォーマンス:
-20.95%
6か月 パフォーマンス:
+12.55%
1年 パフォーマンス:
+117.35%
1日の値動き範囲:
Value
$52.23
$54.52
1週間の範囲:
Value
$50.51
$55.90
52週間の値動き範囲:
Value
$17.11
$73.30

Anaptysbio Inc Stock (ANAB) Company Profile

Name
名前
Anaptysbio Inc
Name
セクター
Healthcare (1079)
Name
電話
858-362-6295
Name
住所
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
Name
職員
104
Name
Twitter
@anaptysbio
Name
次回の収益日
2026-08-05
Name
最新のSEC提出書
Name
ANAB's Discussions on Twitter

Compare ANAB vs VRTX, REGN, ARGX, RVMD, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ANAB icon
ANAB
Anaptysbio Inc
53.36 1.59B 232.39M -26.79M 4.41M -1.0804
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
477.10 121.57B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
762.63 69.95B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
853.82 55.61B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
187.53 39.98B 742.00K -1.37B -1.07B -7.0731
ONC icon
ONC
Beone Medicines Ltd Adr
316.01 33.81B 5.76B 514.49M 1.10B 4.4813

Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-01-07 再開されました UBS Buy
2025-10-13 開始されました Barclays Overweight
2025-06-04 アップグレード H.C. Wainwright Neutral → Buy
2025-02-04 開始されました Wolfe Research Outperform
2024-12-11 ダウングレード H.C. Wainwright Buy → Neutral
2024-12-02 ダウングレード BTIG Research Buy → Neutral
2024-07-22 開始されました H.C. Wainwright Buy
2024-07-19 アップグレード JP Morgan Neutral → Overweight
2024-04-16 開始されました Leerink Partners Outperform
2024-04-11 開始されました Wells Fargo Overweight
2024-03-12 アップグレード Wedbush Neutral → Outperform
2024-02-26 開始されました BTIG Research Buy
2024-02-21 開始されました Stifel Buy
2024-02-16 開始されました Piper Sandler Overweight
2023-05-22 アップグレード JP Morgan Underweight → Neutral
2023-05-18 開始されました TD Cowen Outperform
2023-01-06 ダウングレード Raymond James Outperform → Mkt Perform
2022-11-01 アップグレード Guggenheim Neutral → Buy
2022-09-19 再開されました H.C. Wainwright Buy
2022-09-13 ダウングレード Truist Buy → Hold
2022-09-01 開始されました Raymond James Outperform
2022-03-22 ダウングレード Guggenheim Buy → Neutral
2021-06-22 開始されました H.C. Wainwright Buy
2021-05-21 開始されました UBS Neutral
2021-03-16 アップグレード Truist Hold → Buy
2021-03-09 ダウングレード Wedbush Outperform → Neutral
2021-03-08 ダウングレード JP Morgan Overweight → Underweight
2021-02-11 アップグレード JP Morgan Underweight → Overweight
2020-10-27 アップグレード Wedbush Neutral → Outperform
2020-10-14 アップグレード Guggenheim Neutral → Buy
2019-11-08 ダウングレード JP Morgan Overweight → Underweight
2019-11-08 ダウングレード Jefferies Buy → Hold
2019-11-08 ダウングレード SunTrust Buy → Hold
2019-11-08 ダウングレード Wedbush Outperform → Neutral
2019-06-21 ダウングレード Credit Suisse Outperform → Neutral
2019-06-21 ダウングレード Stifel Buy → Hold
2018-12-20 開始されました H.C. Wainwright Buy
2018-11-21 開始されました JP Morgan Overweight
2018-07-19 開始されました Credit Suisse Outperform
2018-04-04 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2018-03-27 繰り返されました Stifel Buy
2018-03-06 繰り返されました Stifel Buy
2018-02-15 繰り返されました SunTrust Buy
2018-01-23 繰り返されました Credit Suisse Outperform
2017-11-15 開始されました SunTrust Buy
2017-11-09 開始されました Jefferies Buy
2017-10-11 繰り返されました RBC Capital Mkts Outperform
2017-09-15 開始されました RBC Capital Mkts Outperform
すべてを表示

Anaptysbio Inc (ANAB) 最新ニュース

pulisher
Jul 28, 2026

Eversept Partners LP Decreases Stock Position in AnaptysBio, Inc. $ANAB - MarketBeat

Jul 28, 2026
pulisher
Jul 27, 2026

AnaptysBio Inc (ANAB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

AnaptysBio Inc (ANAB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

ANAB|AnaptysBio Inc|Price:53.775|Chg%:+0.165 - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

AnaptysBio Inc (ANAB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

First Light Asset Management LLC Decreases Stock Holdings in AnaptysBio, Inc. $ANAB - MarketBeat

Jul 27, 2026
pulisher
Jul 27, 2026

AnaptysBio Inc (ANAB) Cash Flow - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

AnaptysBio Inc (ANAB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

AnaptysBio Inc (ANAB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

ANAB|AnaptysBio Inc|Price:53.486|Chg%:-0.124 - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

ANAB|AnaptysBio Inc|Price:54.150|Chg%:-0.760 - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

TradingKey - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

AnaptysBio, Inc. $ANAB Shares Sold by Granahan Investment Management LLC - MarketBeat

Jul 26, 2026
pulisher
Jul 26, 2026

AnaptysBio Inc (ANAB) Income Statement - TradingKey

Jul 26, 2026
pulisher
Jul 25, 2026

Anaptysbio, Inc Net Worth (2026) - GuruFocus

Jul 25, 2026
pulisher
Jul 25, 2026

Affinity Asset Advisors LLC Boosts Position in AnaptysBio, Inc. $ANAB - MarketBeat

Jul 25, 2026
pulisher
Jul 24, 2026

Hsbc Holdings PLC Buys New Shares in AnaptysBio, Inc. $ANAB - MarketBeat

Jul 24, 2026
pulisher
Jul 24, 2026

AnaptysBio Inc (ANAB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 24, 2026
pulisher
Jul 23, 2026

AnaptysBio (NASDAQ:ANAB) Trading Up 5.6%Here's What Happened - MarketBeat

Jul 23, 2026
pulisher
Jul 23, 2026

Barclays Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $75 - Moomoo

Jul 23, 2026
pulisher
Jul 22, 2026

AnaptysBio Declines 2.14% as Shares Test Key Support ZoneVolatility Term Structure - dars.gov.et

Jul 22, 2026
pulisher
Jul 22, 2026

AnaptysBio Q1 2026 Earnings: Significant EPS Miss as Pipeline Costs Weigh on ResultsEarnings Call Q&A - dars.gov.et

Jul 22, 2026
pulisher
Jul 22, 2026

Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX), UnitedHealth (UNH) and AnaptysBio (ANAB) - The Globe and Mail

Jul 22, 2026
pulisher
Jul 21, 2026

H.C. Wainwright Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $95 - Moomoo

Jul 21, 2026
pulisher
Jul 20, 2026

AnaptysBio (NASDAQ:ANAB) Shares Down 6.2%Here's Why - MarketBeat

Jul 20, 2026
pulisher
Jul 18, 2026

AnaptysBio, Inc.'s Equity Buyback announced on March 24, 2025 has expired with 3,444,079 shares, representing 11.5% for $68.63 million. - marketscreener.com

Jul 18, 2026
pulisher
Jul 17, 2026

AnaptysBio (NASDAQ:ANAB) Trading 5.3% HigherShould You Buy? - MarketBeat

Jul 17, 2026
pulisher
Jul 16, 2026

Is AnaptysBio (ANAB) Undervalued Following Its Jemperli Royalty Appeal And GSK Trial? - Sahm

Jul 16, 2026
pulisher
Jul 15, 2026

AnaptysBio (NASDAQ:ANAB) Shares Gap DownWhat's Next? - MarketBeat

Jul 15, 2026
pulisher
Jul 15, 2026

Significant Decline for AnaptysBio (ANAB) as Shares Drop Over 10% - GuruFocus

Jul 15, 2026
pulisher
Jul 15, 2026

Barclays Keeps Their Buy Rating on AnaptysBio (ANAB) - The Globe and Mail

Jul 15, 2026
pulisher
Jul 14, 2026

AnaptysBio (NASDAQ:ANAB) Shares Down 7%Time to Sell? - MarketBeat

Jul 14, 2026
pulisher
Jul 14, 2026

What Makes AnaptysBio (ANAB) an Investment Bet? - Yahoo Finance

Jul 14, 2026
pulisher
Jul 14, 2026

Laughing Water Capital Q2 2026 Letter - Seeking Alpha

Jul 14, 2026
pulisher
Jul 14, 2026

TD Cowen Remains a Buy on AnaptysBio (ANAB) - The Globe and Mail

Jul 14, 2026
pulisher
Jul 13, 2026

Form 144 ANAPTYSBIO For: 13 July By Investing.com - Investing.com Australia

Jul 13, 2026
pulisher
Jul 13, 2026

AnaptysBio (NASDAQ: ANAB) insider files to sell 10,694 shares after option exercise - Stock Titan

Jul 13, 2026
pulisher
Jul 13, 2026

TD Cowen Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $75 - Moomoo

Jul 13, 2026
pulisher
Jul 11, 2026

AnaptysBio (ANAB) Holds Near Support as Biotech Sentiment Remains CautiousCup and Handle - dars.gov.et

Jul 11, 2026
pulisher
Jul 10, 2026

Is AnaptysBio (ANAB) outperforming other medical stocks this year? - MSN

Jul 10, 2026
pulisher
Jul 10, 2026

AnaptysBio, Inc. (NASDAQ:ANAB) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Jul 10, 2026
pulisher
Jul 08, 2026

Should AnaptysBio’s (ANAB) Russell Index Removal Prompt a Rethink of Its Liquidity and Investor Base? - simplywall.st

Jul 08, 2026
pulisher
Jul 05, 2026

(ANAB) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Jul 05, 2026
pulisher
Jul 02, 2026

Analysts Are Bullish on Top Healthcare Stocks: MindWalk Holdings (HYFT), AnaptysBio (ANAB) - The Globe and Mail

Jul 02, 2026
pulisher
Jul 01, 2026

UBS Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $76 - Moomoo

Jul 01, 2026
pulisher
Jul 01, 2026

AnaptysBio, Inc. Financial Disclosures & Filings - TradingView

Jul 01, 2026
pulisher
Jul 01, 2026

CapForce IBD 50 ETF's AnaptysBio Inc(ANAB) Holding History - GuruFocus

Jul 01, 2026
pulisher
Jun 30, 2026

Form 144 ANAPTYSBIO For: 30 June By Investing.com - Investing.com Nigeria

Jun 30, 2026
pulisher
Jun 30, 2026

[144] ANAPTYSBIO, INC SEC Filing - Stock Titan

Jun 30, 2026
pulisher
Jun 30, 2026

AnaptysBio Is Maintained at Buy by UBS - Moomoo

Jun 30, 2026
pulisher
Jun 30, 2026

Is AnaptysBio’s (ANAB) Index Exit and Office Sublease Quietly Reframing Its Strategic Focus? - simplywall.st

Jun 30, 2026

Anaptysbio Inc (ANAB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$90.58
price down icon 2.44%
$119.52
price down icon 2.82%
$33.91
price down icon 1.77%
$58.43
price down icon 1.00%
$205.52
price up icon 0.02%
ONC ONC
$316.01
price down icon 1.88%
大文字化:     |  ボリューム (24 時間):